In our HPV16-E6/E7 transgenic mouse model of tongue tumors, we found that tumor lesions in the tongue were much smaller in the inhibitor-treated and siRNA-treated groups compared with the DEPC-treated group, which might be due to decreased Cdc42 expression and increased E-cad expression. This evidence concerns the gene CDH1 and tongue neoplasm.